SCHEMBL727114

SCHEMBL727114

CC1CC(=O)CCCCCCCCCCC(=O)C1

nearest known ligand 0.53

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 2/20 0.53
TRIM33 Q9UPN9 2/20 0.53
ALDH1A1 P00352 1/20 0.53
KMT2A Q03164 1/20 0.42
CRBN Q96SW2 1/20 0.42
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA4 P22748 1/20 0.39
THRB P10828 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.32
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22320959 1.00 TRIM24 (0.53) TRIM24TRIM33ALDH1A1KMT2ACRBN
SCHEMBL21925266 1.00 TRIM24 (0.53) TRIM24TRIM33ALDH1A1KMT2ACRBN
SCHEMBL21925246 1.00 TRIM24 (0.53) TRIM24TRIM33ALDH1A1KMT2ACRBN
SCHEMBL1655400 1.00 TRIM24 (0.53) TRIM24TRIM33ALDH1A1KMT2ACRBN
SCHEMBL1655628 1.00 TRIM24 (0.53) TRIM24TRIM33ALDH1A1KMT2ACRBN
SCHEMBL19745458 0.97 TRIM24 (0.50) TRIM24TRIM33ALDH1A1KMT2ACRBN
SCHEMBL24304032 0.87 KMT2A (0.54) TRIM24TRIM33ALDH1A1KMT2ACRBN
SCHEMBL1870048 0.87 KMT2A (0.54) TRIM24TRIM33ALDH1A1KMT2ACRBN
SCHEMBL7739757 0.87 KMT2A (0.54) TRIM24TRIM33ALDH1A1KMT2ACRBN
SCHEMBL316736 0.87 KMT2A (0.54) TRIM24TRIM33ALDH1A1KMT2ACRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662194-A1 NEW METHOD FOR OZONOLYSIS AND REDUCTIVE QUENCHING OF OZONIDES P2 Science, Inc. (US) 2025-12-17 EP claimed
EP-3911656-B1 SYNTHESIS OF 14-METHYL-16-OXABICYCLO[10.3.1]HEXADEC-12-ENE INT FLAVORS & FRAGRANCES INC (US) 2025-09-17 EP claimed
US-20250214920-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND KAO CORPORATION (JP) 2025-07-03 US claimed
US-20250214921-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND KAO CORPORATION (JP) 2025-07-03 US claimed
EP-4501896-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND Kao Corporation (JP) 2025-02-05 EP claimed
EP-4501897-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND Kao Corporation (JP) 2025-02-05 EP claimed
CN-113166167-B Process for preparing bicyclic enol ethers 弗门尼舍有限公司 2024-11-19 CN claimed
EP-3870587-B1 PROCESS FOR PREPARING BICYCLIC ENOLETHER FIRMENICH & CIE (CH) 2024-09-11 EP claimed
WO-2024167957-A1 NEW METHOD FOR OZONOLYSIS AND REDUCTIVE QUENCHING OF OZONIDES P2 SCIENCE, INC. (US) 2024-08-15 WO claimed
US-12037341-B2 Process for preparing bicyclic enolether FIRMENICH SA (CH) 2024-07-16 US claimed
US-8173846-B2 Substituted cyclohexenones FIRMENICH SA (CH) 2012-05-08 US claimed
JP-4793930-B2 2011-10-12 JP claimed
EP-2247564-B1 SUBSTITUTED CYCLOHEXENONES FIRMENICH & CIE (CH) 2011-06-29 EP claimed
US-20100274059-A1 SUBSTITUTED CYCLOHEXENONES FIRMENICH SA (CH) 2010-10-28 US claimed
EP-1718591-B1 A PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE CYCLOHEXENONES FIRMENICH & CIE (CH) 2008-10-15 EP claimed
US-7332633-B2 Process for the preparation of optically active cyclohexenones FIRMENICH SA (CH) 2008-02-19 US claimed
JP-2007522257-A 2007-08-09 JP claimed
US-20060252967-A1 Process for the preparation of optically active cyclohexenones FIRMENICH SA (CH) 2006-11-09 US claimed
EP-1718591-A1 A PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE CYCLOHEXENONES FIRMENICH SA (CH) 2006-11-08 EP claimed
WO-2005077875-A1 A PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE CYCLOHEXENONES FIRMENICH SA (CH) 2005-08-25 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250214920-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND CYP4F2, DUOX1, BCKDK TRIM24 3623/4885TRIM33 4651/4885ALDH1A1 973/4885
US-20250214921-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND HSD17B7, HSD17B12, BCKDK TRIM24 3967/4885TRIM33 4561/4885ALDH1A1 699/4885
US-20100274059-A1 SUBSTITUTED CYCLOHEXENONES OXER1, ORC3, OR10J3 TRIM24 3668/4885TRIM33 2859/4885ALDH1A1 175/4885
US-20060252967-A1 Process for the preparation of optically active cyclohexenones KCNJ11, KCNJ1, KCNK17 TRIM24 3248/4885TRIM33 4606/4885ALDH1A1 1221/4885
US-12037341-B2 Process for preparing bicyclic enolether CYP3A4, CYP1A2, CYP2F1 TRIM24 3035/4885TRIM33 3843/4885ALDH1A1 592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.